[Analysis of age-related incidence (by circulation) of age-associated pathology in 2018-2023 on the example of the municipal polyclinic of Saint-Petersburg.]

Autor: Saginbaev UR; Saint-Petersburg Institute of Bioregulation and Gerontology, 3 Dynamo av., St. Petersburg 197119, Russian Federation, e-mail: ural-spb-sag@mail.ru., Rukavishnikova SA; Saint-Petersburg Institute of Bioregulation and Gerontology, 3 Dynamo av., St. Petersburg 197119, Russian Federation, e-mail: ural-spb-sag@mail.ru., Akhmedov TA; Saint-Petersburg Institute of Bioregulation and Gerontology, 3 Dynamo av., St. Petersburg 197119, Russian Federation, e-mail: ural-spb-sag@mail.ru., Davydova EP; Saint-Petersburg Institute of Bioregulation and Gerontology, 3 Dynamo av., St. Petersburg 197119, Russian Federation, e-mail: ural-spb-sag@mail.ru., Merkulova IV; Saint-Petersburg City Polyclinic № 54, 9 Vasenko str., St. Petersburg 195197, Russian Federation.
Jazyk: ruština
Zdroj: Advances in gerontology = Uspekhi gerontologii [Adv Gerontol] 2024; Vol. 37 (1-2), pp. 67-71.
Abstrakt: From the age of 25-30, the likelihood of developing pathological processes associated with aging begins to increase. Age-associated diseases (AAD) are a heterogeneous group of pathologies that are more likely to develop as they age. Clinically, the early development of AAD is identical to premature aging with all the ensuing consequences. Timely targeted detection of AAD will slow down age-related processes. In order to study the peculiarities of age-related morbidity (by circulation), age-associated pathology, the study included 5 600 people with a newly diagnosed diagnosis who applied to the municipal polyclinic of St. Petersburg in 2017-2023. During the study, heterogeneity of the timing of the manifestation of AAD at the population level was found. In addition, the median age of patients was comparable to the value of the developed age-specific incidence index, which serves as a basis for continuing research in order to comprehensively assess the properties and limitations of the considered indicator.
Databáze: MEDLINE